Cover Image

Beta‐thalassaemia intermedia due to a complex alpha‐globin rearrangement and a heterozygous beta thalassaemia mutation

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Victor Marin, Yoann Huguenin, Lucile Bessi, Laurent Weinmann, Vanessa Augis, Arnaud Desclaux, Louis Lebreton, Stephanie Dulucq, Julian Boutin
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	British Journal of Haematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hearing loss in beta‐thalassaemia: An Italian multicentre case–control study
by: Renzo Manara, et al.
Published: (2024)

Extensive extramedullary haematopoiesis in a patient with non‐transfusion‐dependent beta‐thalassaemia
by: Laura Distelmaier, et al.
Published: (2025)

The double edge of erythropoietic modulation in thalassaemia
by: Paolo Ricchi
Published: (2025)

Iron overload and morbidities in Chinese with non‐transfusion‐dependent thalassaemia
by: Wing‐yan Leung, et al.
Published: (2025)

Reframing thalassaemia syndrome as a benign haematopoietic stem cell disorder
by: Aurelio Maggio, et al.
Published: (2024)

Obesity, liver steatosis and metabolic syndrome: The hidden enemies in transfusion‐dependent thalassaemia
by: Padmapani Padeniya, et al.
Published: (2024)

Contextualizing prophylactic red blood cell antigen matching in the lifelong care of sickle cell disease and thalassaemia patients
by: Eric A. Gehrie, et al.
Published: (2024)

Assessment of neurocognitive functioning in sickle cell disease and thalassaemia and the association with silent cerebral infarcts, cerebral haemodynamics and oxygen metabolism
by: Liza Afzali‐Hashemi, et al.
Published: (2025)

Comparative analysis of mortality patterns and treatment strategies in thalassaemia and sickle cell disease patients: A 12‐year study
by: Sophia Delicou, et al.
Published: (2025)

Neutrophil extracellular traps induced by activated platelets as a cause of neutrophil–platelet aggregation in β‐thalassaemia/haemoglobin E patients
by: Rattanawan Thubthed, et al.
Published: (2026)

Proteomic profiling of circulating β‐thalassaemia/haemoglobin E extra‐cellular vesicles reveals that association with immunoglobulin induces membrane vesiculation
by: Kunwadee Phongpao, et al.
Published: (2024)

Prevention and management of indwelling catheter‐related thrombosis in sickle cell disease and thalassaemia: A British Society for Haematology Good Practice Paper
by: George Woodward, et al.
Published: (2024)

Acquired haemophilia A in paediatric patients: A retrospective French cohort of eight cases
by: Paul Mouthon, et al.
Published: (2024)

Cholesterol‐conjugated miR‐29b induces fetal haemoglobin expression via γ‐globin promoter demethylation in the Townes mouse model for sickle cell anaemia
by: Chithra D. Palani, et al.
Published: (2025)

Large B‐cell lymphoma with mystery rearrangement: Applying Hi‐C to the detection of clinically relevant structural abnormalities
by: Daniel Prior, et al.
Published: (2024)

Reed–Sternberg‐like cells in central nervous system relapse of diffuse large B‐cell lymphoma
by: Radu Chiriac, et al.
Published: (2025)

Chronic lymphocytic leukaemia extravaganza: Vacuolated lymphoma cells
by: Radu Chiriac, et al.
Published: (2025)

Monocytic transition in B‐lymphoblastic leukaemia with a DUX4 rearrangement
by: Jingwei Li, et al.
Published: (2026)

Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients
by: Vincent Alcazer, et al.
Published: (2024)

Improvement in cutaneous disease with menin inhibitor monotherapy in KMT2A rearranged AML
by: John Chadwick, et al.
Published: (2025)

Immunological features of acquired pure red cell aplasia: Specific human leucocyte antigen alleles, signal transducer and activator of transcription 3 mutations and a unique T‐cell receptor beta motif
by: Naruaki Yamashita, et al.
Published: (2026)

Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm
by: Stéphane De Botton, et al.
Published: (2024)

Epigenetic dysregulation and therapeutic targeting of RET receptor tyrosine kinase in high‐risk KMT2A ‐rearranged acute myeloid leukaemia
by: Arundhati Chavan, et al.
Published: (2025)

Comorbidities and mutations including single‐ and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia—A population‐based study
by: Matilda Kjellander Kynning, et al.
Published: (2025)

EPAS1 ‐mutated paragangliomas associated with haemoglobin disorders
by: Maxence Mancini, et al.
Published: (2024)

Single‐cell transcriptional consequences of leukaemogenic SETBP1 mutations
by: Mi K. Trinh, et al.
Published: (2026)

Repurposing pacritinib to target MYD88 ‐mutated Waldenström macroglobulinaemia
by: Shirong Liu, et al.
Published: (2025)

Incidence and clinical correlates of NFE2 mutations in myeloid neoplasms
by: Iván Martín Castillo, et al.
Published: (2024)

A CD10‐negative adult B‐lymphoblastic leukaemia with amplification of KMT2A without rearrangement: A case report and review of the English literature
by: Huan‐You Wang, et al.
Published: (2024)

Optimizing treatment selection and timing of allogeneic haematopoietic stem cell transplantation in acute myeloid leukaemia with concurrent feline McDonough sarcoma (FMS)‐like tyrosine kinase 3 internal tandem duplication, nucleophosmin 1 and deoxyribonucleic acid (DNA) methyltransferase 3 alpha mutations
by: Ruixin Li, et al.
Published: (2026)

Novel IKZF1 rearrangement identified in a patient with blastic plasmacytoid dendritic cell neoplasm decreased haematopoietic stem cell function and promoted plasmacytoid dendritic cell abnormality
by: Le Yin, et al.
Published: (2024)

Distinct subtypes of post‐transplant lymphoproliferative disorders: CHIP‐like mutations in early lesions and substantial mutational differences between EBV‐positive and EBV‐negative diffuse large B‐cell lymphomas
by: Vanesa‐Sindi Ivanova, et al.
Published: (2025)

Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene
by: Antonio Marzollo, et al.
Published: (2024)

Single gene mutations and prognosis in limited‐stage follicular lymphoma treated with radiation therapy
by: Samantha A. Hershenfeld, et al.
Published: (2024)

From mutation to management: Advancing Langerhans cell histiocytosis treatment through combination therapies
by: Akiva Diamond
Published: (2024)

The efficacy of targeted and immune‐based therapies in adults with TP53‐mutated acute lymphoblastic leukaemia
by: Hoda Pourhassan, et al.
Published: (2025)

Acute myeloid leukaemia with SRSF2 and BRAF mutations preceded by histiocytic proliferation in the bone marrow
by: Minako Mori, et al.
Published: (2025)

EGLN1 mutations in Cis can induce congenital erythrocytosis with thromboses by increasing protein instability
by: Serge Carillo, et al.
Published: (2025)

Clinical features, mutational landscape and their prognostic impact in Chinese paediatric patients with T‐cell lymphoblastic lymphoma
by: Yang Li, et al.
Published: (2025)

Somatic co‐alteration signatures are prognostic in high‐grade TP53‐mutated myeloid neoplasms
by: Emily O. Symes, et al.
Published: (2024)